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Background: Saikosaponin-d (SSd), a monomer terpenoid purified from the Chinese herbal drug Radix bupleuri,
has multiple effects, including anticancer properties. However, the effect of SSd on tumors exposed to radiation is
largely unknown. To investigate the radiosensitizing effect of SSd and its possible mechanism, we combined SSd
with radiation therapy to treat SMMC-7721 hepatocellular carcinoma cells under oxia and hypoxia.
Methods: Cell growth, apoptosis, and cell cycle distribution were examined after treatment with SSd alone,
radiation alone, and their combinations under oxia and hypoxia. The protein and mRNA levels of p53, Bcl2, and BAX
were measured using western blot analysis and RT-PCR, respectively.
Results: Treatment with SSd alone and radiation alone inhibited cell growth and increased apoptosis rate at the
concentration used. These effects were enhanced when SSd was combined with radiation. Moreover, SSd
potentiated the effects of radiation to induce G0/G1 arrest in SMMC-7721 cells, and reduced the G2/M-phase
population under hypoxia. However, under oxia, SSd only potentiated the effects of radiation to induce G0/G1
arrest, but not G2/M-phase arrest. These effects of SSd alone, radiation alone, and their combination, were
accompanied by upregulated expression of p53 and BAX and downregulation of Bcl2 expression under oxia and
hypoxia.
Conclusion: SSd potentiates the effects of radiation on SMMC-7721 cells; thus, it is a promising radiosensitizer. The
radiosensitizing effect of SSd may contribute to its effect on the G0/G1 and G2/M checkpoints of the cell cycle.Background
Primary hepatocellular carcinoma (HCC), which com-
prises 90% of all malignant tumors that develop in the
liver, is one of the most devastating human malignancies:
it can cause death within a few months unless treated
properly [1,2]. Early diagnosis and treatment through sur-
gical resection or transcatheteral arterial chemoemboliza-
tion (TACE) significantly improves the patient survival
rate [3]. However, a substantial number of patients with
HCC are unsuitable for surgery or TACE, and must be* Correspondence: wangxijing@21cn.com
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reproduction in any medium, provided the ortreated with using alternative methods. Radiotherapy has
long been used in cancer therapy and it is frequently used
to treat patients with HCC [4,5]. Oxic conditions are im-
portant for maximizing the response of cancer cells and
tissues to radiation therapy. However, hypoxia is a com-
mon feature of the solid human tumor, which causes re-
sistance to radiation in cancer cells during radiation
therapy.
To overcome the hypoxic resistance, several ap-
proaches have been developed over several decades to
alter the hypoxic status of cancer cells during radiation
therapy. Numerous new hypoxic radiosensitizers have
recently been developed and some have even been clin-
ically evaluated [6]. Many herbs and other botanicaltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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radiosensitizers or hypoxic sensitizers [7]. However, the
clinical utility of radiosensitizers remains disputed.
Saikosaponin-d (SSd), an extract from the traditional
Chinese herb Bupleurum chinensis DC, reported exhibits
anti-inflammatory [8,9], hepatoprotective [10,11], anti-
angiogenic [12], and anti-cancer properties [13-16]. Our
recent clinical practice of combining SSd administration
with radiation in treating patients with hepatocellular
carcinoma revealed that this joint treatment was more
effective than either monotherapy alone, indicating a
contributory effect of SSd on radiotherapy. However, the
mechanism underlying radiosensitization effect of SSd on
HCC cells remains unclear. To investigate the radiosensi-
tizing effect and therapeutic efficacy of SSd, we combined
SSd with radiation therapy to treat SMMC-7721 HCC
cells under oxic and hypoxic conditions.
Methods
Cell culture
The cells were cultured in RPMI-1640 medium (PAA
Laboratories GmbH, Austria) supplemented with 10%
fetal bovine serum (FBS), 100 units/mL penicillin G, and
100 μg/mL streptomycin sulfate (GIBCO, Invitrogen)
under a humidified 5% CO2 atmosphere at 37°C, and
passaged once per 2 d to 3 d. During the logarithmic
growth period, the cells were collected by 0.25% trypsin
digestion. After counting the living cells, the cell density
was adjusted to 5 × 104 /mL, and then propagated by
seeding into 96-well plates for further treatments, in-
cluding oxic and hypoxic incubation. The oxic culture
was performed by incubating the cells in RPMI-1640
medium with 10% FBS at 37°C. For hypoxia induction,
the cells grown to 80% to 90% confluence were
trypsinized and counted, and seeded into a 6-well plate
(5 × 103cells/well), followed by incubation with 100 μM
cobalt chloride (CoCl2) for 4 h in 4 mL of serum-free
medium before X-ray irradiation at a dose rate of
400 cGy/min (Clinac 2100EX; Varian Medical Systems
Inc., CA) [17,18]. All of the experimental procedures
were conducted in accordance with the Guide for the
Care and Use of Laboratory Animals of the National In-
stitutes of Health. Experimental protocols were approved
by the Animal Care and Use Regulation of Xi’an Jiaotong
University (Certificate No. 22–9601018).
SSd preparation and experimental groups
SSd and CoCl2 were obtained from Sigma Chemical
(St. Louis, MO). SSd was dissolved in dimethylsulfoxide
(DMSO, Sigma, St Louis, MO, USA) and stored at −20°C.
The desired final concentrations were achieved by dilution
with RPMI-1640. The SMMC-7721 cells were treated with
radiation, SSd, or PX-478 (PX, Millipore, USA) alone or incombination with radiation and SSd or PX-478. Radiation
was performed using a 6 MV X-ray irradiation equipment
(Clinac 2100EX; Varian Medical Systems Inc., CA) at a
dose rate of 400 cGy/min. The distance between the cells
and the radiation source were maintained at 100 cm. SSd
was administered at different concentrations. For the joint
treatment, the radiation dose was set to 2 Gy, the regular
clinical radiation dose that induced moderate cell apop-
tosis rate. SSd was added to the cultures 2 h prior to radi-
ation. The control cultures received the carrier solvent
consisting of 0.1% DMSO.Cell viability assay
Cell viability was measured using an MTT assay under
oxic condition or CoCl2-induced hypoxic condition after
4 h of chemical hypoxic culture. The SMMC-7721 cells
were seeded into a 96-well plate (5 × 103 cells/well), and
then incubated at 37°C in 5% CO2 for different periods
of time as designed. Then, MTT solution (5 mg/mL)
(Sigma, St Louis, MO, USA) was added (20 μL/well) and
the cells were incubated for another 4 h. The superna-
tants were removed and the formazan crystals were
dissolved in 200 μL of DMSO. Finally, the optical density
was determined at 492 nm using a multimicroplate test
system (POLARstar OPTIMA, BMG Labtechnologies,
Germany). The growth inhibition rate was calculated
and plotted using the average data in quadruplicate.FCM apoptosis assay
After treatment, the cells were harvested and the pellet
was suspended in 100 μL of binding buffer according to
the manufacturer’s instructions of an Annexin V-FITC/PI
kit (BD Biosciences, USA), stained with 5 μL of Annexin
V-FITC and 10 μL of PI, and then incubated for 15 min at
room temperature. Afterwards, another 400 μL of binding
buffer was added. The cells were transferred into a BD
Falcon® tube, and the percentage of the apoptotic cells
in each sample was analyzed via FACSCalibur MT flow
cytometer (Becton Dickinson Technologies, USA). The
results represent the mean ± SD of three independent
experiments.FCM cell cycle analysis
After treatment, the cells were harvested, fixed with ice-
cold 70% ethanol, and stored at −20°C until analysis. The
cells were then washed in phosphate-buffered saline, and
resuspended in 50 μg/mL PI solution containing 150 μg/mL
RNase A for 15 min at 37°C, and analyzed through FCM
using FACSCalibur MT flow cytometer (Becton Dickinson
Technologies, USA) and ModFit program (Verity Soft-
ware House, Topsham, MN). The data represent three
independent experiments.
Figure 1 Effects of saikosaponin-d and radiation on the growth
of SMMC-7721 hepatocellular carcinoma cells. All data are
presented as mean ± SD. SSd: saikosaponin-d; IR: radiation. *P < 0.05,
**P < 0.01 vs. control.
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After treatment, cell lysates were prepared with RIPA
buffer containing a protease inhibitor cocktail. The
homogenates were centrifuged for 10 min at 20,000 × g,
and the supernatants were collected. The protein con-
centrations in the supernatants were determined using a
NanoDrop® ND-1000 spectrophotometer (Thermo Fisher
Scientific Inc.). The total cell lysates were subjected to
SDS–PAGE on 10% SDS–acrylamide gel. The separated
proteins were transferred onto PVDF membranes (Millipore,
USA) and incubated with primary antibodies against
p53, bcl2, and Bax, followed by incubation with HRP-
conjugated secondary antibodies (Santa Cruz, CA).
Afterward, the membrane was stripped and incubated
with primary anti- β-actin antibodies (Santa Cruz,
USA). The bands of protein and β-actin were visualized
using Thermo Scientific Pierce® chemiluminescence
substrate and the optical density of the bands were
detected using a CCD camera, recorded and quantified
with Syngene G Box (Syngene, UK), and compared with
the relative control β-actin. The analysis was conducted
at least thrice for each experiment.
Real time PCR detection
After treatment, total RNA was isolated from the
SMMC-7721 cells using Trizol Reagent® (Invitrogen Life
Technologies, USA) according to the instructions of the
manufacturer. The quality and quantity of the RNA
samples were detected using a NanoDrop® ND-1000
spectrophotometer. The cDNA was synthesized using
TaqMan® Reverse Transcription Reagents (ABI Life
Technologies, USA) from 1 μg of RNA. RT-PCR detec-
tion was carried out on an ABI 7300 system using an
SYBR® Green PCR Master Mix kit and predesigned pri-
mer/probe pairs for P53, bcl2, Bax, and β-actin (Santa
Cruz Biotechnology, Inc.). The sequences of the primers
were as follows: p53 (Forward: 5′-CCACCATCCACT
ACAACTACAT-3′,Reverse:5′-AGGACAGGCACAAAC
A-CG-3′), bcl2 (Forward: 5′-CAAATGCTGGACTGAA
AAATTGTA-3′, Reverse: 5′-TATT TTCTAAGGACG
GCATGATCT-3′), BAX(Forward:5′-GACACCTGAGCT
GACCTTG G-3′, Reverse: 5′-GAGGAAGTCCAGTGT
CCAGC-3′), and β-actin (Forward: 5′-TGGCACCCAGC
ACAATGAA-3′, Reverse: 5′-CTAAGTCATAGTCCGCC
TAGAA GCA-3′). The reaction mixture (25 μL) contains
12.5 μL of SYBR Green PCR Master Mix, 1 μL (10 μM) of
each forward primer, 1 μL (10 μM) of each reverse primer,
2 μL (100 ng) of each cDNA template, and 8.5 μL of
ddH2O. The thermal cycling parameters were as fol-
lows: 95°C for 10 min for Taq polymerase activation,
followed by 40 cycles of 95°C for 15 s, 60°C for 1 min.
Normalization and analyses of the fold changes in tar-
get gene expression were carried out with β-actin as
the internal reference via the 2–ΔΔCT method [19]and the Applied Biosystems GeneAmp 5700 SDS software.
The analysis was conducted at least thrice for each
experiment.
Statistical analysis
All values are expressed as the mean ± standard deviations
(SD). Statistical analysis was performed with a Student’s
t-test using SPSS 13.0 statistical software. Differences
with P < 0.05 were considered statistically significant.
Results
Influence of SSd on radiation-induced growth inhibition
of SMMC-7721 cells
In the first experiment, cell viability was determined
using an MTT assay. Under oxia or hypoxia, SSd alone
and radiation alone inhibited the growth of SMMC-7721
cells. The inhibitory effect was further enhanced when
SSd was combined with radiation (Figure 1 p < 0.01). We
found that 1 μg/mL SSd did not significantly inhibit
the hepatoma cells under oxia and hypoxia. However,
combining SSd with radiation had a significantly in-
creased inhibitory effect on HCC, and increased their
sensitivity to radiation, especially under hypoxic condi-
tions, which is more significant than that under oxic
conditions. In addition, 3 μg/mL SSd was significantly
more effective than 1 μg/mL SSd. These results indicate
that the combination treatment induced significant cell
growth inhibition in a dose dependent manner. Under
oxia, irradiation followed by treatment with 1 μg/mL
SSd increased the inhibition rate from 17.9 ± 3.42% to
23.1 ± 3.85%; under hypoxia, the inhibition rate in-
creased from 12.8 ± 3.01% to 27.8 ± 4.52%. These results
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than the individual treatments, especially under hypoxic
conditions.Influence of SSd on the radiation-induced apoptosis of
SMMC-7721 cells
The apoptosis of SMMC-7721 cells induced by SSd, ra-
diation, or their combination was determined via flow
cytometry, with PX-478, an inhibitor of HIF-1α, as the
positive control. The 3 μg/mL SSd treatment signifi-
cantly induced the apoptosis of SMMC-7721 under both
oxic and hypoxic conditions compared with the control
(Figure 2A and B; p < 0.05). In addition, no significant
differences were observed between oxia and hypoxia in
terms of SSd-induced cell apoptosis (p > 0.05), although
the cell apoptosis under oxia showed greater potential
than under hypoxia. The percentage of apoptotic cells in
the 2 Gy radiation treatment was higher under oxic con-
ditions than under hypoxic conditions (Figure 2A and B,
p < 0.05). Critically, the combination therapy of SSd withB
A
Figure 2 Effects of saikosaponin-d and radiation on apoptosis in hep
apoptotic changes before and after treatment under oxia and hypoxia; B. A
IR: radiation. *p < 0.05, **p < 0.01 vs. control.radiation (2 Gy) induced more apoptosis in SMMC-7721
cells under both oxic and hypoxia conditions than both
SSd alone and radiation therapy alone (Figure 2A and B;
p < 0.01). Hypoxic conditions enhanced the effect of
radiation-induced apoptosis of the hepatoma cells more
than oxic conditions in the combined treatment (Figure 2A
and B; P < 0.05). Moreover, we also found that hypoxic
conditions significantly enhanced the radiation-induced
apoptosis of hepatoma cells was when combined with
thePX-478, unlike under oxic conditions.SSd altered cell cycle distribution
To determine the mechanism underlying the potentiat-
ing effect of SSd on radiation-induced apoptosis in
SMMC-7721 cells, we analyzed the alteration in cell
cycle using flow cytometry after every intervention. The
results are shown in Figure 3. In the oxia group, the G0/
G1-phase cells increased after exposure to SSd alone
and radiation alone, whereas the S phase population de-
creased (Figures 3A and C; p < 0.05). However, theatocellular carcinoma cell SMMC-7721. A. Flow cytometry shows




Figure 3 Effect of saikosaponin-d and radiation on the cell cycle distribution of SMMC-7721 human hepatocellular carcinoma cells
under oxia and hypoxia. A. Changes in cell cycle distribution under oxia; B. changes in cell cycle distribution under hypoxia; C. Statistical
analysis showing the changes in cell cycle progression before and after intervention under oxia; D. Statistical analysis showing the changes in cell
cycle progression before and after intervention under hypoxia. SSd: saikosaponin-d; IR: radiation. *p < 0.05, ** p < 0.01 vs. control.
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tered (p > 0.05). These results suggest that the G1-phase
arrest decreased the S-phase population. Moreover, theSSd and radiation combination treatment increase the
G0/G1 arrest and decreased the S-phase population
(Figure 3A and C; p < 0.01). Under hypoxia, SSd alone,
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G1 arrest and decreased the S-phase population. Com-
bined SSd and radiation treatment also further en-
hanced cell cycle arrest than exposure alone. Moreover,
hypoxia significantly increased the effect of radiation
alone on the G2/M-phase (Figures 3B and D; p < 0.05).
Radiation exposure after SSd treatment almost completely
abolished G2/M arrest (Figures 3B and D; p < 0.05).
Meanwhile, a similar cell cycle arrest was induced under
hypoxia in the PX-478 plus radiation group. In summary,
the radiosensitization effect of SSd in SMMC-7721 cells
under hypoxia is related to the reduction in G2/M-phase
population and the increase in G0/G1 arrest, whereas the
radiosensitization was related to the increase in G0/G1A
B C
Figure 4 Effect of saikosaponin-d and radiation on the p53 levels and
carcinoma cells under oxia and hypoxia. A. Western blot analysis of p53
p53. C. Change of Bax/Bcl-2 ratio. SSd: saikosaponin-d; IR: radiation; *p < 0.0arrest, but not to the decrease in G2/M phase arrest under
oxia.
Effects of SSd on the expression of radiation-induced p53
and the changes of bcl2/BAX ratio
To determine whether the cell apoptosis induced by
SSd, PX-478, radiation alone, and their combination is
related to the p53-bcl2/BAX pathway, we investigated
the p53 expression level and the bcl2/BAX ratio in the
SMMC-7721 cells under oxia and hypoxia. Western blot
analysis revealed that SSd alone and radiation alone sig-
nificantly upregulated p53 expression and significantly
decreased the bcl2/BAX ratio under oxia and hypoxia
(Figure 4A–C; p < 0.05). These observations demonstratethe bcl2/BAX ratio in SMMC-7721 human hepatocellular
, Bax, and Bcl-2 levels under oxia and hypoxia. B. Relative expression of
5, ** p < 0.01 vs. control.
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p53-bcl2/BAX pathway. However, the upregulated p53
expression and the reduction in the bcl2/BAX ratio in
the SSd with radiation and the PX-478 with radiation
treatments were more significant than those with SSd
alone and with PX-478 alone (Figure 4A–C; p < 0.05).
Therefore, SSd potentiates the response of SMMC-7721
cells to radiation at the molecular level. Moreover, PX-
478 alone upregulated p53 expression and reduced the
bcl2/BAX ratio under hypoxia, but not under oxia.
Effects of SSd on radiation-induced mRNA expression of
p53, BAX, and bcl2
To confirm whether cell apoptosis induced by SSd, radi-
ation, and their combination is related to the p53-bcl2/
BAX pathway, we analyzed the mRNA levels of p53,
bcl2, and BAX in SMMC-7721 cells under oxia and hyp-
oxia. Under oxia, the mRNA levels of p53 and BAX were
elevated after exposure to SSd alone, radiation alone,
and their combinations, but not with PX-478 alone. By
contrast, the bcl2 mRNA levels were decreased. Simi-
larly, the mRNA levels of p53 and BAX increased under
hypoxia, whereas bcl2 decreased with SSd alone, PX-478
alone, and their combination with radiation (Figure 5A–
C; p < 0.05, p < 0.01). In addition, we also found that all
treatments were more effective under hypoxia than
under oxia, especially the combined treatments. Thus,
these observations confirm that the cell apoptosis in-
duced by SSd alone, PX-478 alone, radiation alone, and
their combinations is related to the p53-bcl2/BAX
pathway.
Discussion
Over the past 20 years, a large number of herbs and
other botanical formulations have been developed into
radiosensitizers or hypoxic sensitizers, many of which
have already undergone clinical evaluation and showedBA
Figure 5 Effect of saikosaponin-d and radiation on the mRNA levels o
carcinoma cells under normoxia and hypoxia. A. Fold changes in p53 m
SSd: saikosaponin-d; IR: radiation; *p < 0.05, ** p < 0.01 vs. control.favorable effect with safety and lower toxicity [7]. SSd,
an extract from the traditional Chinese herbs Bupleurum
chinensis DC, has various pharmacologic properties in-
cluding anti-cancer effect [13-15]. In this study, we
found that incubating SMMC-7721 cells with SSd sig-
nificantly decrease their cell viability under oxia and
hypoxia. In addition, incubating the SMMC-7721 cells
with SSd prior to irradiation further decreased cell via-
bility at each concentration used. Treatment with 1 μg/mL
SSd did not induce apoptosis in SMMC-7721 cells under
oxia and hypoxia. However, treatment with SSd com-
bined with radiation caused a more significant dose-
dependent apoptosis-inducing effect, especially under
hypoxic conditions. This finding implies that SSd has a
potential radiosensitization effect on SMMC-7721 cells
under oxia and hypoxia.
Replicating cells manifest cell-cycle progression delay
in response to radiation-induced DNA damage because
of activation of cell cycle checkpoints [7]. Such check-
points at the G1–S transition and at the G2–M transi-
tion are involved in detecting and correcting DNA
damage. The tumor suppressor protein p53 is a critical
regulator of the cell cycle checkpoints that execute the
G1/S checkpoint in response to DNA damage and in-
duce G0/G1 arrest after irradiation [20-22]. Aside from
promoting cell cycle arrest, p53 also participates in the
activity of the oncogene bcl2 family to trigger apoptosis.
Both Bcl2 and Bax are transcriptional targets of p53.
The oncogene-derived protein Bcl2 negative controls the
cellular suicide machinery pathway. The Bcl2 homolo-
gous protein Bax promotes cell death by competing with
Bcl2. Although Bax–Bax homodimers act as apoptosis
inducers, Bcl2–Bax heterodimer formation promotes the
survival signal for cells, which induces cell cycle arrest
and apoptosis in response to DNA damage [23]. Our
study found that, the levels of p53 and BAX were ele-
vated under oxia and hypoxia after exposure to SSdC
f p53, bcl2 and BAX in SMMC-7721 human hepatocellular
RNA; B. Folds changes in bcl-2 mRNA; C. Fold changes in BAX mRNA;
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the bcl2 levels were decreased. Thus, the cell apoptosis
induced by SSd and radiation may involved activation of
the p53/Bcl2 pathway.
To investigate the mechanism underlying the radio-
sensitization effect of SSd on HCC cells, we analyzed the
changes in the cell cycle progression using flow cytome-
try after intervention. The results showed that SSd alone
and radiation alone induced G0/G1-phase arrest in the
SMMC-7721 cells under oxia and hypoxia, which was
further enhanced by the SSd and radiation combination
treatment, which is accompanied by the decrease in the
S-phase population. The findings reflect the activation of
the G1/S checkpoint. In addition, radiation alone in-
duced typical G2/M phase arrest under hypoxia, which
was almost completely abrogated by the combination
treatment. Furthermore, we also found that the cell cycle
arrest was accompanied by elevation in the mRNA and
protein expression of p53 and BAX, and the decrease in
Bcl2. This result may be attributed to the radiosensi-
tization effect of SSd on hepatoma cells.
PX-478, an inhibitor of the hypoxia-inducible factor-
1α (HIF1α), has potent antitumor activity against various
human tumor xenografts associated with the levels of
the HIF1α [24]. We found that PX-478 alone under oxia
did not alter the p53 expression levels in SMMC-7721
cells. Under hypoxia, however, PX-478 alone induced
apoptosis and cell cycle arrest or upregulated p53 ex-
pression. Koh et al. [25] agreed that the cell apoptosis
induced by PX-478 under hypoxia may contribute to its
antitumor activity against HIF-1α expression by increas-
ing the p53 level, whereas the apoptosis induced by PX-
478 does not require oxygen, pVHL, or p53.Conclusion
In summary, SSd increases the radiosensitivity of SMMC-
7721 hepatoma cells and induces apoptosis, especially
under hypoxic conditions. The radiosensitizing effect of
SSd on hepatoma cells is more obvious under hypoxia,
and its mechanism may contribute to its effect on the G0/
G1 and G2/M checkpoints of the cell cycle. Thus, SSd
may be a promising radiosensitizer. However, whether SSd
alone and SSd combined with radiation generates lethal
single stranded DNA breaks or reactive oxygen species re-
quires further study.
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